CEP-2563 is active against MTC (medullary thyroid carcinoma) and blocked tyrosine kinase receptors such as Trk family and the platelet-derived growth factor (PDGF) receptor tyrosine kinase.92 Here, NTRK1 is linked to medullary thyroid gland carcinoma.